Millennium Management’s Orchard Therapeutics plc American Depositary Shares ORTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-238,852
| Closed | -$3.93M | – | 6866 |
|
|
2023
Q4 | $3.93M | Buy |
+238,852
| New | +$3.76M | ﹤0.01% | 2991 |
|
|
2023
Q1 | – | Sell |
-31,952
| Closed | -$119K | – | 7115 |
|
|
2022
Q4 | $119K | Sell |
31,952
-3,935
| -11% | -$17.4K | ﹤0.01% | 5517 |
|
|
2022
Q3 | $179K | Buy |
35,887
+17,741
| +98% | +$98.8K | ﹤0.01% | 5717 |
|
|
2022
Q2 | $106K | Buy |
+18,146
| New | +$102K | ﹤0.01% | 5900 |
|
|
2022
Q1 | – | Sell |
-14,299
| Closed | -$189K | – | 7734 |
|
|
2021
Q4 | $189K | Sell |
14,299
-26,872
| -65% | -$444K | ﹤0.01% | 5946 |
|
|
2021
Q3 | $947K | Buy |
41,171
+38,934
| +1,740% | +$1.16M | ﹤0.01% | 4753 |
|
|
2021
Q2 | $98K | Sell |
2,237
-28,115
| -93% | -$1.57M | ﹤0.01% | 6241 |
|
|
2021
Q1 | $2.2M | Buy |
30,352
+15,436
| +103% | +$1.1M | ﹤0.01% | 3438 |
|
|
2020
Q4 | $644K | Sell |
14,916
-21,384
| -59% | -$958K | ﹤0.01% | 4017 |
|
|
2020
Q3 | $1.49K | Buy |
36,300
+14,297
| +65% | +$739K | ﹤0.01% | 2824 |
|
|
2020
Q2 | $1.32M | Buy |
+22,003
| New | +$2.02M | ﹤0.01% | 2819 |
|
|
2020
Q1 | – | Sell |
-7,792
| Closed | -$1.07M | – | 4670 |
|
|
2019
Q4 | $1.07M | Sell |
7,792
-30,548
| -80% | -$3.71M | ﹤0.01% | 2974 |
|
|
2019
Q3 | $4.55M | Sell |
38,340
-6,823
| -15% | -$952K | 0.01% | 1890 |
|
|
2019
Q2 | $6.32M | Buy |
45,163
+17,742
| +65% | +$3.12M | 0.01% | 1594 |
|
|
2019
Q1 | $4.9M | Sell |
27,421
-1,532
| -5% | -$230K | 0.01% | 1779 |
|
|
2018
Q4 | $4.55M | Buy |
+28,953
| New | +$4.32M | 0.01% | 1652 |
|
Millennium Management's ORTX Position: Q1 2024 in Review
Millennium Management sold out of Orchard Therapeutics plc American Depositary Shares (ORTX) in Q1 2024, closing a stake of 238,852 shares — an estimated $3.93M sold.
Millennium Management first reported a position in ORTX in Q4 2018 and held it in 16 quarters. The position peaked at $6.32M in Q2 2019. 0 funds tracked by Wall St. Rank hold ORTX as of Q1 2024.
- Millennium Management reported no remaining Orchard Therapeutics plc American Depositary Shares position as of Q1 2024 after selling out during the quarter.
- Millennium Management sold 238,852 Orchard Therapeutics plc American Depositary Shares shares in Q1 2024, an estimated $3.93M.
- Millennium Management first reported a position in Orchard Therapeutics plc American Depositary Shares in Q4 2018 and held it in 16 quarters.
- Millennium Management's Orchard Therapeutics plc American Depositary Shares position peaked at $6.32M in Q2 2019.
- 0 funds tracked by Wall St. Rank held Orchard Therapeutics plc American Depositary Shares as of Q1 2024.
Based on Millennium Management's 13F filing for Q1 2024, filed 15 May 2024.